Givosiran
Showing 1 - 6 of 6
Acute Hepatic Porphyria Trial (Givosiran)
No longer available
- Acute Hepatic Porphyria
- Givosiran
- (no location specified)
Jul 14, 2022
Acute Intermittent Porphyria Trial in Sweden, United Kingdom, United States (givosiran (ALN-AS1))
Completed
- Acute Intermittent Porphyria
- givosiran (ALN-AS1)
-
San Francisco, California
- +4 more
Nov 9, 2021
Acute Hepatic Porphyria, Acute Intermittent Porphyria, Porphyria, Acute Intermittent Trial in Worldwide (Givosiran, Placebo)
Completed
- Acute Hepatic Porphyria
- +6 more
- Givosiran
- Placebo
-
Little Rock, Arkansas
- +35 more
May 31, 2022
Patients With Acute Hepatic Porphyria (AHP)
Recruiting
- Acute Hepatic Porphyria
-
Birmingham, Alabama
- +21 more
Aug 11, 2022
Acute Intermittent Porphyria (AIP), Acute Hepatic Porphyria (AHP), Porphyria, Acute Intermittent Trial in Stockholm (Givosiran,
Completed
- Acute Intermittent Porphyria (AIP)
- +3 more
- Givosiran
- 5-probe cocktail
-
Stockholm, SwedenClinical Trial Site
Mar 10, 2019
Acute Intermittent Porphyria Trial in Sweden, United Kingdom, United States (givosiran (ALN-AS1), Sterile Normal Saline (0.9%
Completed
- Acute Intermittent Porphyria
- givosiran (ALN-AS1)
- Sterile Normal Saline (0.9% NaCl)
-
Birmingham, Alabama
- +5 more
Jun 13, 2018